AURORA — Three companies and two individuals were recognized Wednesday night at the first-ever awards dinner sponsored by the Colorado BioScience Association.
Roche Colorado Corp. was named company of the year for 2003. Roche was honored for its innovative way of developing and manufacturing a critical new drug to fight AIDS. The company is also investing $54 million in pollution prevention technology over the next five years.
Innovation of the Year Award went to Globe Immune Inc. for its breakthrough discovery in the field of molecular biology and immunology. The breakthrough will lead to new tools in the fight against cancer and viral diseases, according to a statement issued by the CBA.
The Volunteer of the Year is Myogen’s Derek Cole, director of investor relations. Cole was honored for his efforts in chairing the CBA’s programs committee that was responsible for attracting nearly 2,000 participants to more than 20 programs and events held over the past year.
The Life Science Partner Award was given to Sequel Venture Partners, a Colorado-based firm that has funded many of the state’s leading biotechnology and medical device companies.
Ralph Christofferson was presented with the Individual Lifetime Achievement Award for his work serving on several committees, including chairing the Colorado Biotechnology Association. Christofferson is a partner in Morgenthaler Ventures and former president and CEO of Ribozyme Pharmaceuticals.
Wednesday’s awards dinner, attended by more than 200 people, was held at the Radisson Denver Southeast in conjunction with the BioWest conference, which is in its second year in Denver.